1 Institute of Microbiology, The Czech Academy of Sciences, Czech Republic.
2 Faculty of Medicine, Charles University, Czech Republic.
Lab Anim. 2019 Jun;53(3):271-280. doi: 10.1177/0023677218818605. Epub 2018 Dec 22.
The world-wide incidence of many immune-mediated and metabolic diseases, including those of the intestines and liver, is steadily increasing. Gut microbiota plays a central role in the pathogenesis of these diseases as it mediates environmental changes to the intestinal immune system. Various environmental factors including diet, food additives and medication also trigger the compositional and functional alterations of microbiota, that is, dysbiosis, and this dysbiosis is closely associated with many chronic inflammatory diseases. However, the causal relationship remains unclear for the majority of these diseases. In this review, we discuss essential epidemiological data, known pathogenetic factors including those of genetic and environmental nature, while mainly focusing on the role of gut microbiota in the development of selected intestinal and liver diseases. Using specific examples, we also briefly describe some of the most widely-used animal models including gnotobiotic models and their contribution to the research of pathogenetic mechanisms of the host-microbiota relationship.
全世界范围内许多免疫介导和代谢性疾病的发病率,包括肠道和肝脏疾病,正在稳步上升。肠道微生物群在这些疾病的发病机制中起着核心作用,因为它介导了环境变化对肠道免疫系统的影响。各种环境因素,包括饮食、食品添加剂和药物,也会引发微生物群的组成和功能改变,即微生态失调,而这种微生态失调与许多慢性炎症性疾病密切相关。然而,对于大多数这些疾病来说,其因果关系尚不清楚。在这篇综述中,我们讨论了基本的流行病学数据,以及已知的发病因素,包括遗传和环境因素,同时主要关注肠道微生物群在选定的肠道和肝脏疾病发展中的作用。我们还使用具体的例子,简要描述了一些最广泛使用的动物模型,包括无菌动物模型及其对宿主-微生物群关系发病机制研究的贡献。